MoneyWorks4Me

Kopran rises on receiving approval to sell its Consumer Care Division

15 Jul 2015 Evaluate

Kopran is currently trading at Rs. 62.20, up by 1.90 points or 3.15% from its previous closing of Rs. 60.30 on the BSE.

The scrip opened at Rs. 62.70 and has touched a high and low of Rs. 63.00 and Rs. 61.40 respectively. So far 1,46,000 shares were traded on the counter.

The BSE group 'B ' stock of face value Rs. 10 has touched a 52 week high of Rs. 72.65 on 16-Sep-2014 and a 52 week low of Rs. 40.10 on 15-Jul-2014.

Last one week high and low of the scrip stood at Rs. 63.00 and Rs. 53.60 respectively. The current market cap of the company is Rs. 254.00 crore.

The promoters holding in the company stood at 42.08% while Institutions and Non-Institutions held 2.78% and 55.14% respectively.

Kopran has received an approval for sale of Consumer Care Division with effect from April 01, 2015 along with all its assets and liabilities. The board of directors at their meeting held on July 14, 2015 has approved for the same.

Kopran is currently an integrated Pharmaceutical Company manufacturing a large range of products. It manufactures both Active Pharmaceutical Ingredients and Finished Dosage Forms.


Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..